These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 29368667)

  • 1. Hypervirulent Clostridium difficile Strain Has Arrived in Brazil.
    Pires RN; Monteiro AA; Saldanha GZ; Falci DR; Caurio CFB; Sukiennik TCT; Adam FC; Pasqualotto AC; Martins AF
    Infect Control Hosp Epidemiol; 2018 Mar; 39(3):371-373. PubMed ID: 29368667
    [No Abstract]   [Full Text] [Related]  

  • 2. Clostridium difficile: trend in an Italian Tertiary Care Hospital during fifteen years, 2002-2016.
    Masucci L; Nicolotti N; Graffeo R; Tamburrano A; Archibusacci CM; Nagel D; Quaranta G; Eisendle K; Primus S; Romano L; Mazzella P; Posteraro B; Cammarota G; Sanguinetti M
    Minerva Med; 2019 Apr; 110(2):168-171. PubMed ID: 30821431
    [No Abstract]   [Full Text] [Related]  

  • 3. Toxin A-negative, toxin B-positive Clostridium difficile infection diagnosed by polymerase chain reaction.
    Cheng Y; Du P; Chen C; Yan S; Jia H; Wang J; Yan Q; Feng H; Lu J
    Infect Control Hosp Epidemiol; 2011 May; 32(5):520-2. PubMed ID: 21515990
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of the laboratory in investigations of Clostridium difficile diarrhea.
    Brazier JS
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S228-33. PubMed ID: 8324124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of Clostridium difficile tcdC variant 078 in Marseille, France.
    Cassir N; Fahsi N; Durand G; Lagier JC; Raoult D; Fournier PE
    Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1971-1974. PubMed ID: 28573471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of cross-infection associated to a Brazilian PCR-ribotype of Clostridium difficile in a university hospital in Rio de Janeiro, Brazil.
    Balassiano IT; dos Santos-Filho J; Vital-Brazil JM; Nouér SA; Souza CR; Brazier JS; Ferreira Ede O; Domingues RM
    Antonie Van Leeuwenhoek; 2011 Feb; 99(2):249-55. PubMed ID: 20623188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamate dehydrogenase as confirmatory test for Clostridium difficile toxin A/B-positive stools.
    Bignardi GE; Settle C
    J Hosp Infect; 2010 Aug; 75(4):327-8. PubMed ID: 20227790
    [No Abstract]   [Full Text] [Related]  

  • 8. Antimicrobial prescribing practices in response to different Clostridium difficile diagnostic methodologies.
    Sydnor ER; Lenhart A; Trollinger B; Avdic E; Maragakis LL; Carroll KC; Cosgrove SE
    Infect Control Hosp Epidemiol; 2011 Nov; 32(11):1133-6. PubMed ID: 22011545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of toxigenic Clostridium difficile polymerase chain reaction testing on the clinical microbiology laboratory and inpatient epidemiology.
    Napierala M; Munson E; Skonieczny P; Rodriguez S; Riederer N; Land G; Luzinski M; Block D; Hryciuk JE
    Diagn Microbiol Infect Dis; 2013 Aug; 76(4):534-8. PubMed ID: 23731555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of antigen and two molecular methods for the detection of Clostridium difficile toxins.
    Ylisiurua P; Koskela M; Vainio O; Tuokko H
    Scand J Infect Dis; 2013 Jan; 45(1):19-25. PubMed ID: 22998479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of nosocomial Clostridium difficile infections with toxigenic strains despite negative toxin A and B testing on stool samples.
    Stahlmann J; Schönberg M; Herrmann M; von Müller L
    Clin Microbiol Infect; 2014 Sep; 20(9):O590-2. PubMed ID: 24450741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of value of repeat stool testing for Clostridium difficile toxin.
    Mohan SS; McDermott BP; Parchuri S; Cunha BA
    Am J Med; 2006 Apr; 119(4):356.e7-8. PubMed ID: 16564786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridium difficile infection among immunocompromised patients in Rio de Janeiro, Brazil and detection of moxifloxacin resistance in a ribotype 014 strain.
    Secco DA; Balassiano IT; Boente RF; Miranda KR; Brazier J; Hall V; dos Santos-Filho J; Lobo LA; Nouér SA; Domingues RM
    Anaerobe; 2014 Aug; 28():85-9. PubMed ID: 24907488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of GeneXpert PCR to BD GeneOhm for detecting C. difficile toxin gene in GDH positive toxin negative samples.
    Agaronov M; Karak SG; Maldonado Y; Tetreault J; Aslanzadeh J
    Ann Clin Lab Sci; 2012; 42(4):397-400. PubMed ID: 23090736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First report of Clostridium difficile NAP1/027 in a Mexican hospital.
    Camacho-Ortiz A; López-Barrera D; Hernández-García R; Galván-De Los Santos AM; Flores-Treviño SM; Llaca-Díaz JM; Maldonado-Garza HJ; Bosques-Padilla FJ; Garza-González E
    PLoS One; 2015; 10(4):e0122627. PubMed ID: 25915544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Storage procedures and time influence the detectability of
    Grześkowiak Ł; Riedmüller J; Vahjen W; Zentek J
    J Vet Diagn Invest; 2020 Mar; 32(2):222-225. PubMed ID: 31328697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PCR cycle threshold value predicts the course of Clostridium difficile infection.
    Jazmati N; Hellmich M; Ličanin B; Plum G; Kaasch AJ
    Clin Microbiol Infect; 2016 Feb; 22(2):e7-e8. PubMed ID: 26408277
    [No Abstract]   [Full Text] [Related]  

  • 18. A Successful Strategy to Decrease Hospital-Onset Clostridium difficile.
    Bruno-Murtha LA; Osgood RA; Alexandre CE
    Infect Control Hosp Epidemiol; 2018 Feb; 39(2):234-236. PubMed ID: 29301591
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of two novel chemiluminescence immunoassays for the detection of Clostridium difficile glutamate dehydrogenase and toxin A&B.
    Blaich A; Frei R; Castellano C; Kiessling C; Geschke A; Rentsch KM; Egli A
    J Microbiol Methods; 2017 Apr; 135():63-65. PubMed ID: 28192156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First clinical and microbiological characterization of Clostridium difficile infection in a Croatian University Hospital.
    Novak A; Spigaglia P; Barbanti F; Goic-Barisic I; Tonkic M
    Anaerobe; 2014 Dec; 30():18-23. PubMed ID: 25079669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.